Moderna (MRNA) Stock Jumps 16% Following Positive Flu Vaccine Results and Wall Street Upgrades
Key Takeaways Moderna shares climbed over 16% following the publication of Phase 3 data in the New England Journal of Medicine demonstrating that its mRNA...












